BioCentury
ARTICLE | Clinical News

Tasquinimod: Phase III final data

November 9, 2015 8:00 AM UTC

Active Biotech AB (SSE:ACTI), Lund, Sweden Ipsen Group (Euronext:IPN; Pink:IPSEY), Boulogne-Billancourt, France Product: Tasquinimod ( TASQ) ( ABR-215050) Business: Cancer Molecular target: S100 cal...